Get ready for an exciting announcement for the melanoma community

  • Days
  • Hours
  • Minutes




#GetNaked Spokesperson, Raheem Mostert!


Learn more about our #GetNaked spokesperson Raheem Mostert





NEW Cutaneous Melanoma Patient Guide Stages 0-1

Check out the new guide for patients who were diagnosed with cutaneous melanoma stage 0-1!

MRF Events



MRF Events

Save the Date!

Save the Date for our upcoming celebrations of the melanoma community in Denver and New York City!





Congrats to our Resident/Fellow Grant Recipients!

Learn more about our grant recipients and their research!

News & Press

FDA Announcement


News & Press

FDA Announces Approval of TIL Therapy or AMTAGVI

Learn more about TIL Cell Therapy through our animated patient video!

Join a Miles for Melanoma 5k

Miles for Melanoma

Miles for Melanoma

Join a Miles for Melanoma 5k!

Join melanoma patients, survivors, caregivers and supporters in cities across the US to walk, run and raise life-saving funds for melanoma research. Find a run/walk near you and register your team today!

Join Us In Our Mission To Cure Melanoma

The MRF’s mission is to eradicate melanoma by accelerating medical RESEARCH
while EDUCATING to and ADVOCATING for the melanoma community.

Melanoma is the deadliest form of skin cancer.

Melanoma claims the lives of over 8,290 Americans every year.

Melanoma is the leading cause of cancer death in young women ages 25 – 30 and the second leading cause of cancer death in women ages 30-35.

9 out of 10 cases are considered to be preventable.

Funding Melanoma Research

Funding from The MRF has resulted in:

clinical trials

27 Clinical trials


132 Grants with new collaborations


276 Publications


591 Presentations

Recently Funded Research

Kelsey Montgomery (University of Alabama at Birmingham)

Surveillance and Survivorship in Sentinel Lymph Node Positive Melanoma

Urvashi Joshi (University of Pittsburgh)

Effects of Adjuvant Anti-PD1 on Atypical/Dysplastic Nevi

Afsaneh Amouzegar (University of Texas M.D. Anderson Cancer Center)

Metabolic Dependencies of Melanoma Brain Metastasis

Lilit Karapetyan, MD, MS (H. Lee Moffitt Cancer Center & Research Institute, Inc)

CD40L-Augmented Tumor Infiltrating Lymphocyte Expansion from Core Biopsies

Kevin Nguyen (West Virginia University Research Corporation)

Predictors of Nodal Metastases in Pediatric Melanomas

Alexander Huang, MD (The Trustees of the University of Pennsylvania)

Pharmacodynamic Effect of Radvax on Microbiome-Specific T Cells

Latest News

Cleveland Press Release
Cleveland, OH (July 18, 2024) - The Melanoma Research Foundation (MRF) is thrilled to announce one of the next events
Team Anamoly Press Release
Speech from the 2024 Denver Miles for Melanoma 5K by Randei McTaggart, cutaneous melanoma survivor and MRF supporter:  "Good morning
Adina Greene Press Release
Guest Blog Post by Adina Greene, Fourth-Year Medical Student and MRF Advocate and Volunteer: Fourth-year medical student at the University
Chicago Press Release
Chicago, IL (July 8, 2024) - The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its

Optimize Your Treatment

Although the MRF cannot recommend a specific doctor, clinic or clinical trial, the Melanoma Treatment Center Finder and Clinical Trial Finder will help you find an experienced melanoma treatment team, as well as give you the opportunity to explore clinical trials. Did you know that clinical trials are often viewed as the best treatment option for Stage II, III and IV melanoma patients?

Please remember to use this information as a starting point in your search for a healthcare team that best meets your needs. All information regarding your treatment should be discussed with your healthcare professional.


Shop to Support MRF.

Grab some merch to support our mission to eradicate melanoma by accelerating medical research while educating to and advocating for the melanoma community.




The MRF is committed to providing the most up-to-date education and support resources for melanoma patients and their loved ones.